CD4 and glioblastoma: Similar results were obtained in the TCGA-GBM HiSeq cohort (Fig. 5CD), suggesting that poor prognosis might be related to the activation of effector memory CD4 T cells, immature B cells, and the inhibition of type 2 T helper cells.